Skip to content

US · NAII · PACKAGED FOODS

Natural Alternatives International, Inc. (NAII) intrinsic value and stock valuation

$0.88as of 2026-11-21 · Mkt cap 14.18M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Natural Alternatives International, Inc. DCF and intrinsic value

InvestorsCraft values NAII with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from NAII’s statements →

Natural Alternatives International, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Consumer Defensive · Packaged Foods Carlsbad, CA 92008 nai-online.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$129.9M+1.8% 5y CAGRd
20112025
Net income
-$-13.57M
20112025
Free cash flow
$2.32M
20112025
Total equity
$68.4M-0.8% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$129.9M$113.8M$154M$171M$178.5M
Operating income-$-8.66M-$-8.53M$4.71M$13.7M$13.7M
Net income-$-13.57M-$-7.22M$2.52M$10.7M$10.8M
EPSd-$-2.28M-$-1.23M$428.6K$1.74M$1.69M
Operating cash flow$5.93M-$-1.5M$7.02M$11.9M$20.8M
Capital expenditure-$-3.61M-$-3.02M-$-13.52M-$-26.49M-$-5.11M
Free cash flow$2.32M-$-4.51M-$-6.5M-$-14.62M$15.7M
Total assets$151.9M$162.3M$134.2M$146M$120.3M
Total debt$59M$60.3M$30.9M$31.8M$16.5M
Net debt$46.7M$48.3M$17.3M$10M-$-15.65M
Total equity$68.4M$82.6M$88.8M$88.5M$80.1M
Cash and short-term investments$12.3M$12M$13.6M$21.8M$32.1M
Income statement
20252024202320222021
Revenue$129.9M$113.8M$154M$171M$178.5M
Cost of revenue$120.6M$106.9M$135.9M$140.5M$148.1M
Gross profit$9.29M$6.87M$18.2M$30.5M$30.4M
Research and development expenses$1.8M$1.9M$2.1M$2.5M$1.9M
Selling, general and administrative expenses$16.6M$15.4M$14.9M$17M$16.8M
Other expenses-$-400K-$-1.9M-$-3.52M-$-2.62M-$-1.9M
Operating expenses$18M$15.4M$13.5M$16.8M$16.8M
Cost and expenses$138.5M$122.3M$149.3M$157.3M$164.9M
Interest income$170K$180K$30K$0.00$0.00
Interest expense$920K$360K$450K$80K$120K
Depreciation and amortization$4.56M$4.65M$7.08M$6.91M$4.34M
Ebitda-$-2.7M-$-4.46M$11.1M$20.7M$16.6M
Operating income-$-8.66M-$-8.53M$4.71M$13.7M$13.7M
Total other income/expenses, net-$-2.08M-$-930K-$-1.16M-$-20K-$-1.55M
Income before tax-$-10.74M-$-9.46M$3.56M$13.7M$12.1M
Income tax expense$2.83M-$-2.25M$1.03M$2.95M$1.36M
Net income-$-13.57M-$-7.22M$2.52M$10.7M$10.8M
Weighted average shares outstanding$5.95M$5.87M$5.86M$6.12M$6.29M
Weighted average diluted shares outstanding$5.95M$5.87M$5.88M$6.16M$6.38M
Balance sheet
20252024202320222021
Cash and short-term investments$12.3M$12M$13.6M$21.8M$32.1M
Net receivables$14.9M$16.9M$7.33M$17.5M$19M
Inventory$24.9M$24.3M$29.7M$32.5M$27M
Total current assets$59.3M$61.6M$57M$76.8M$80.4M
Property, plant and equipment, net$91.9M$95.8M$74.2M$66.3M$38.2M
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$0.00$80K$0.00$0.00$0.00
Total non-current assets$92.7M$100.7M$77.1M$69.3M$39.9M
Total assets$151.9M$162.3M$134.2M$146M$120.3M
Accounts payable$15.4M$12.7M$7.78M$16.2M$11.9M
Short-term debt$4.43M$4.89M$2.76M$940K$0.00
Deferred revenue$1.36M$300K$320K$140K$1.72M
Total current liabilities$28.8M$23.5M$15.9M$23.9M$22.1M
Long-term debt$54.6M$55.4M$28.2M$30.9M$16.5M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$54.7M$56.3M$29.5M$33.6M$18.1M
Capital lease obligations$48.2M$47.7M$21.4M$22.1M$16.5M
Total liabilities$83.5M$79.8M$45.4M$57.5M$40.2M
Common stock$90K$90K$90K$90K$90K
Retained earnings$59.4M$73M$80.2M$77.7M$67M
Accumulated other comprehensive income (loss)-$-1.42M-$-20K-$-80K$1.7M-$-560K
Total equity$68.4M$82.6M$88.8M$88.5M$80.1M
Total investments$0.00$80K$0.00$0.00$0.00
Total debt$59M$60.3M$30.9M$31.8M$16.5M
Net debt$46.7M$48.3M$17.3M$10M-$-15.65M
Cash flow statement
20252024202320222021
Net income-$-13.57M-$-7.22M$2.52M$10.7M$10.8M
Depreciation and amortization$4.56M$4.65M$4.25M$4.17M$4.34M
Stock-based compensation$980K$1.2M$1.01M$970K$1.43M
Change in working capital$1.57M-$-3.35M-$-1.23M-$-7.43M$1.08M
Accounts receivable$2.25M-$-9.87M$11.8M$640K-$-810K
Inventory-$-620K$5.45M$2.78M-$-5.47M$970K
Accounts payable$2.86M$5.39M-$-8.61M$3.06M$0.00
Net cash provided by operating activities$5.93M-$-1.5M$7.02M$11.9M$20.8M
Investments in property, plant and equipment-$-3.61M-$-3.02M-$-13.52M-$-26.49M-$-5.11M
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities-$-3.61M-$-3.02M-$-13.47M-$-26.46M-$-5.04M
Common stock issued$0.00$0.00$0.00$0.00$40K
Common stock repurchased-$-180K-$-220K-$-1.5M-$-5.5M-$-4.15M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-1.97M$2.89M-$-1.78M$4.29M-$-14.11M
Net change in cash$340K-$-1.62M-$-8.23M-$-10.3M$1.66M
Cash at end of period$12.3M$12M$13.6M$21.8M$32.1M
Operating cash flow$5.93M-$-1.5M$7.02M$11.9M$20.8M
Capital expenditure-$-3.61M-$-3.02M-$-13.52M-$-26.49M-$-5.11M
Free cash flow$2.32M-$-4.51M-$-6.5M-$-14.62M$15.7M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Natural Alternatives International, Inc.

        Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.

        CEO
        Mark A. LeDoux
        Employees
        293
        Beta
        0.36

        Explore

        Frequently asked questions

        What is the intrinsic value of Natural Alternatives International, Inc. (NAII)?

        InvestorsCraft does not currently publish an intrinsic value for NAII. How the IC value is calculated.

        Is NAII undervalued?

        InvestorsCraft does not publish an undervaluation signal for NAII at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.